144
0001834021
XXXXXXXX
LIVE
0001650648
4D Molecular Therapeutics, Inc.
001-39782
5858 Horton Street
Suite 455
Emeryville
CA
94608
1-510-505-2680
David Kirn
Officer
Class A Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
69076
1157713.76
55244211
08/19/2026
NASD
Class A Common
12/15/2020
Acquired from issuer in private transaction
Issuer
N
19076
12/15/2020
None
Class A Common
03/06/2025
Acquired as compensation -- Stock Options
Issuer
N
50000
03/06/2025
Compensation -- Cashless exercise / same-day sale
N
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/03/2026
12415
124722.33
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
06/01/2026
1922
19257.86
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
06/22/2026
114746
1200851.31
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
07/09/2026
42608
548177.48
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
07/10/2026
15725
189233.08
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/04/2026
26842
274596.34
The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c).
08/19/2026
01/09/2026
Goldman Sachs & Co. LLC on behalf of David Kirn